Category Archives: Patient Enrolment

‘Patient centricity’ – what does this ‘revolution’ really mean?

I’m sure you have heard mention of ‘patient centricity’ – a buzz-term for behaviour that brings patients more closely involved with – or should we say to the centre of? – their own care. The same term describes behaviour towards … Continue reading

Posted in Patient Enrolment | Leave a comment

How to improve and retain the participation of minorities in clinical trials – lessons learned from the Maryland Regional Community Network Program

Challenges in recruiting patients from minorities Successfully recruiting ethnic minorities into clinical trials is a major challenge for healthcare professionals. There are obvious benefits to the individual and their community, and to the integrity of scientific research through the diversity … Continue reading

Posted in Central and Eastern Europe, Patient Enrolment, Social Media | Leave a comment

Creating culturally appropriate enrolment approaches for education and retention of patients in clinical trials in Eastern Europe

Difficulties in recruiting patients One of the biggest problems in conducting clinical trials successfully is patient recruitment. Another challenge is assuring diversity in clinical trials enrolment which is essential for eliminating health disparities as low enrollment and participation of racial/ethnic minorities … Continue reading

Posted in Central and Eastern Europe, Patient Enrolment | Leave a comment

A clinical trial completed within six months: Making a hard task possible

Interview with Paul Duxbury  Managing Director, Nasaleze International Ltd What is your experience with clinical trials? We’ve been involved since 2003 when we formed the company. We realised that, if we wanted to be taken seriously, we needed evidence-based trial work. … Continue reading

Posted in Central and Eastern Europe, Clinical Accelerator, Patient Enrolment | Tagged | Leave a comment

Ease patient recruitment through collaboration: how some cancer trials could enrol patients more easily

The Lung Cancer Master Protocol (Lung-MAP) trial uses genomic profiling to match patients with experimental treatments. It is hoped that the design will reduce recruitment and infrastructure problems for researchers. If your medication is a gene-targeted biologic for cancer, a … Continue reading

Posted in Patient Enrolment | Leave a comment